Predictive and patient-monitoring biomarkers: precision in the management of colorectal cancer

Biomark Med. 2020 Apr;14(5):335-339. doi: 10.2217/bmm-2020-0025. Epub 2020 Apr 6.

Authors

Georgios Pappas-Gogos^{1

2}, Evangelos G Baltagiannis^{1

2}, Ioannis D Kyrochristos^{1

2}, Demosthenes E Ziogas^{1

3}, Anna Goussia⁴, Michail Mitsis², Dimitrios H Roukos^{1

2

5}

Affiliations

¹ Centre for Biosystems and Genome Network Medicine, Ioannina University, Ioannina, Greece.
² Department of Surgery, University Hospital of Ioannina, Ioannina, Greece.
³ Department of Surgery, 'G Hatzikosta' General Hospital, Ioannina, Greece.
⁴ Department of Pathology, University Hospital of Ioannina, Ioannina, Greece.
⁵ Department of Systems Biology, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece.

PMID: 32250157
DOI: 10.2217/bmm-2020-0025

No abstract available

Keywords: biomarker development; colorectal cancer; next-generation sequencing; tumor heterogeneity.

Publication types

Editorial

MeSH terms

Biomarkers, Tumor / blood*
Colorectal Neoplasms / blood*
Colorectal Neoplasms / diagnosis
Colorectal Neoplasms / genetics
Colorectal Neoplasms / physiopathology*
Gene Expression Profiling
Genomics
Humans
Monitoring, Physiologic*
Prognosis

Substances

Biomarkers, Tumor